60
Participants
Start Date
April 7, 2021
Primary Completion Date
April 7, 2025
Study Completion Date
November 7, 2025
Mycophenolate Mofetil
Day 1: MMF 500 mg twice a day Day 2: MMF 1000 mg twice a day
Solu-Medrol
2 mg/kg/day
Ursodeoxycholic acid
Patients with mixed or cholestatic liver injury pattern will also be administrated peroral UDCA according to weight
Prednisone tablet
Shift from solu-medrol IV to peroral prednisolon. A tapering plan will be performed.
RECRUITING
Rigshospitalet, Copenhagen
RECRUITING
Herlev University Hospital, Herlev
RECRUITING
Odense University Hospital, Odense
RECRUITING
Aarhus University Hospital, Aarhus
NOT_YET_RECRUITING
Aalborg University Hospital, Aalborg
Inge Marie Svane
OTHER